Advanced Accelerator Applications completes EUR41m fundraising
Advanced Accelerator Applications, a specialist in molecular nuclear medicine (MNM), has completed a capital increase of EUR41m. The capital increase will help fund expansion plans and finance clinical trials of its portfolio of MNM diagnostic and therapeutic products. The fundraising came from existing and new shareholders, including private investors




